- ISIN
- US30050B1017
- CUSIP
- 30050B101
- Sector
- Healthcare
- Industry
- Health Information Services
- IPO Date
- Jun 5, 2015
Highlights
- Market Cap
- $347.57M
- Enterprise Value
- $226.26M
- EPS (TTM)
- -$4.38
- Total Revenue (TTM)
- $1.89B
- Gross Profit (TTM)
- $264.34M
- EBITDA (TTM)
- -$353.64M
- Year Range
- $2.10 - $10.08
- Target Price
- $6.38
- ROA (TTM)
- -26.43%
- ROE (TTM)
- -125.26%
- Avg. Volume (1M)
- 3M
- Avg. Volume Value (1M)
- $15.99M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
EVH Performance Chart
Evolent Health, Inc. (EVH) is down 22.8% since the beginning of the year. At $3 per share, EVH is trading 69.3% below its 52-week high of $10. Investors who bought $1,000 worth of EVH shares 5 years ago would now be looking at an investment worth $135.
Loading charts...
Compare this symbol against anything
Returns By Period
Evolent Health, Inc. (EVH) has returned -22.75% so far this year and -69.04% over the past 12 months. Over the last ten years, EVH has returned -18.37% per year, falling short of the S&P 500 Index benchmark, which averaged 13.26% annually.
Evolent Health, Inc.
- 1D
- -2.83%
- 1M
- -45.88%
- 6M
- -3.74%
- YTD
- -22.75%
- 1Y
- -69.04%
- 3Y*
- -53.33%
- 5Y*
- -33.03%
- 10Y*
- -18.37%
- ALL TIME*
- -14.61%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
EVH Monthly Returns History
Based on dividend-adjusted daily data since Jun 5, 2015, EVH's average daily return is +0.02%, while the average monthly return is +0.56%. At this rate, an investment would double in approximately 10.3 years.
Historically, 51% of months were positive and 49% were negative. The best month was Apr 2026 with a return of +64.5%, while the worst month was Nov 2024 at -44.7%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 7 months.
On a daily basis, EVH closed higher 50% of trading days. The best single day was Mar 26, 2020 with a return of +31.3%, while the worst single day was Nov 8, 2024 at -45.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -19.75% | 1.25% | -29.85% | 64.47% | 5.33% | 37.22% | -42.99% | -22.75% | |||||
| 2025 | -7.11% | -13.97% | 5.34% | 4.12% | -24.44% | 51.14% | -10.75% | -3.98% | -12.33% | -21.16% | -37.03% | -4.76% | -64.44% |
| 2024 | -10.96% | 15.30% | -3.30% | -15.40% | -23.61% | -9.77% | 21.97% | 37.14% | -11.57% | -17.43% | -44.67% | -12.93% | -65.94% |
| 2023 | 14.74% | 8.66% | -7.31% | 12.20% | -19.97% | 3.98% | 0.30% | -16.06% | 6.74% | -10.28% | 13.79% | 18.81% | 17.63% |
| 2022 | -14.31% | 12.40% | 21.20% | -14.80% | 2.22% | 9.17% | 10.68% | 8.12% | -2.23% | -11.47% | -9.49% | -2.47% | 1.48% |
| 2021 | 6.49% | 18.04% | 0.25% | 7.23% | -10.30% | 8.70% | 8.62% | 7.06% | 26.22% | -5.58% | -11.17% | 6.42% | 72.61% |
Benchmark Metrics
Evolent Health, Inc. has an annualized alpha of -10.83%, beta of 1.24, and R2 of 0.12 versus S&P 500 Index. Calculated based on daily prices since June 05, 2015.
- This stock participated in 167.31% of S&P 500 Index downside but only 53.77% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.12 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -10.83%
- Beta
- 1.24
- R²
- 0.12
- Upside Capture
- 53.77%
- Downside Capture
- 167.31%
Return for Risk
Risk / Return Rank
EVH ranks 8 for risk / return — above 8% of stocks peers on PortfoliosLab. Its historical combined result is below most peers; review the five component ranks for context.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Evolent Health, Inc. (EVH) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| EVH | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.31 | ||
| Sortino ratioReturn per unit of downside risk | -3.58 | ||
| Omega ratioGain probability vs. loss probability | 0.82 | 1.25 | -0.43 |
| Calmar ratioReturn relative to maximum drawdown | -0.89 | 2.00 | -2.89 |
| Martin ratioReturn relative to average drawdown | -1.29 | 8.49 | -9.78 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Evolent Health, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Evolent Health, Inc. was 94.54%, occurring on Mar 30, 2026. The portfolio has not yet recovered.
The current Evolent Health, Inc. drawdown is 92.22%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-94.54%Mar 2026 | 3y 6mo | — | 3y 10moSep 2022 - now | — |
-87.34%Mar 2020 | 1y 5mo | 1y 6mo | 3y 4dSep 2018 - Sep 2021 | COVID crash2020 |
-62.34%Feb 2016 | 6mo 21d | 4mo 22d | 11mo 13dAug 2015 - Jul 2016 | — |
-61.61%Nov 2017 | 5mo 8d | 10mo 3d | 1y 3moJun 2017 - Sep 2018 | — |
-44.55%Dec 2016 | 4mo 19d | 5mo 10d | 9mo 29dAug 2016 - Jun 2017 | — |
Drawdown Indicators
| EVH | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.54% | -56.78% | -37.76% |
Max Drawdown (1Y)Largest decline over 1 year | -78.28% | -9.10% | -69.18% |
Max Drawdown (3Y)Largest decline over 3 years | -93.75% | -18.90% | -74.85% |
Max Drawdown (5Y)Largest decline over 5 years | -94.54% | -25.43% | -69.11% |
Max Drawdown (10Y)Largest decline over 10 years | -94.54% | -33.92% | -60.62% |
Current DrawdownCurrent decline from peak | -92.22% | -1.58% | -90.64% |
Average DrawdownAverage peak-to-trough decline | -41.20% | -10.70% | -30.50% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 54.04% | 2.14% | +51.90% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Evolent Health, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Evolent Health, Inc. is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for EVH relative to other companies in the Health Information Services industry. Currently, EVH has a P/S ratio of 0.2. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for EVH in comparison with other companies in the Health Information Services industry. Currently, EVH has a P/B value of 0.9. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with EVH
Add Evolent Health, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with EVH